关注
Claire Lynnette Adams
Claire Lynnette Adams
在 plymouth.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett’s esophagus
C Palles, L Chegwidden, X Li, JM Findlay, G Farnham, FC Giner, ...
Gastroenterology 148 (2), 367-378, 2015
1192015
Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism
J Dunn, S Ferluga, V Sharma, M Futschik, DA Hilton, CL Adams, ...
EBioMedicine 40, 77-91, 2019
502019
The value of serum neopterin, interferon-gamma levels and interleukin-12B polymorphisms in predicting acute renal allograft rejection
GK Chin, CL Adams, BS Carey, S Shaw, WY Tse, ER Kaminski
Clinical & Experimental Immunology 152 (2), 239-244, 2008
362008
Differences in the kinetics, amplitude, and localization of ERK activation in anergy and priming revealed at the level of individual primary T cells by laser scanning cytometry
CL Adams, AM Grierson, AM Mowat, MM Harnett, P Garside
The Journal of Immunology 173 (3), 1579-1586, 2004
362004
Global proteome and phospho-proteome analysis of merlin-deficient meningioma and schwannoma identifies PDLIM2 as a novel therapeutic target
K Bassiri, S Ferluga, V Sharma, N Syed, CL Adams, E Lasonder, ...
EBioMedicine 16, 76-86, 2017
312017
Cellular prion protein (PrPC) in the development of Merlin-deficient tumours
L Provenzano, Y Ryan, DA Hilton, J Lyons-Rimmer, F Dave, EA Maze, ...
Oncogene 36 (44), 6132-6142, 2017
292017
Complete analysis of the B‐cell response to a protein antigen, from in vivo germinal centre formation to 3‐D modelling of affinity maturation
CL Adams, MKL Macleod, E James Milner‐White, R Aitken, P Garside, ...
Immunology 108 (3), 274-287, 2003
272003
GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma
C Negroni, DA Hilton, E Ercolano, CL Adams, KM Kurian, D Baiz, ...
EBioMedicine 59, 2020
242020
Direct quantitation of T cell signaling by laser scanning cytometry
AM Grierson, P Mitchell, CL Adams, AMI Mowat, JM Brewer, MM Harnett, ...
Journal of immunological methods 301 (1-2), 140-153, 2005
192005
Constitutive activation of the EGFR–STAT1 axis increases proliferation of meningioma tumor cells
S Ferluga, D Baiz, DA Hilton, CL Adams, E Ercolano, J Dunn, K Bassiri, ...
Neuro-oncology advances 2 (1), vdaa008, 2020
182020
A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated …
CL Adams, E Ercolano, S Ferluga, A Sofela, F Dave, C Negroni, ...
International Journal of Molecular Sciences 21 (4), 1273, 2020
152020
Tracking lymphocytes in vivo
CL Adams, N Kobets, GR Meiklejohn, OR Millington, AM Morton, ...
Arch Immunol Ther Exp (Warsz) 52 (3), 173-187, 2004
142004
Fibulin-2: a novel biomarker for differentiating grade II from grade I meningiomas
AA Sofela, DA Hilton, S Ammoun, D Baiz, CL Adams, E Ercolano, ...
International Journal of Molecular Sciences 22 (2), 560, 2021
122021
Serum neopterin as an indicator of increased risk of renal allograft rejection
BS Carey, R Jain, CL Adams, KY Wong, S Shaw, WY Tse, ER Kaminski
Transplant immunology 28 (2-3), 81-85, 2013
122013
miR-497 and 219 in blood aid meningioma classification
A Abdelrahman, C Negroni, F Sahm, CL Adams, T Urbanic-Purkart, ...
Journal of neuro-oncology 160 (1), 137-147, 2022
112022
Tracking antigen-specific lymphocytes in vivo
CL Adams, CM Rush, KM Smith, P Garside
Cell Migration in Inflammation and Immunity: Methods and Protocols, 133-146, 2003
42003
Towards a Cre-based recombination system for generating integrated DNA repertoires site-specifically in yeast
BG Davies, CL Adams, S Aijaz, JPL Cox
Biotechnology letters 24, 727-733, 2002
42002
A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas
LL van de Weijer, E Ercolano, T Zhang, M Shah, MC Banton, J Na, ...
Acta Neuropathologica Communications 11 (1), 198, 2023
32023
The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma
J Lyons Rimmer, E Ercolano, D Baiz, M Makhija, A Berger, T Sells, ...
Cancers 12 (7), 1744, 2020
32020
Strategies for producing therapeutic antibodies in yeast
CL Adams
PQDT-Global, 1999
21999
系统目前无法执行此操作,请稍后再试。
文章 1–20